https://www.selleckchem.com/products/fg-4592.html
Ketamine has emerged as a fast-acting and powerful antidepressant, but no head to head trial has been performed, Here, ketamine is compared with electroconvulsive therapy (ECT), the most effective therapy for depression. Hospitalized patients with unipolar depression were randomized (11) to thrice-weekly racemic ketamine (0.5 mg/kg) infusions or ECT in a parallel, open-label, non-inferiority study. The primary outcome was remission (Montgomery Åsberg Depression Rating Scale score ≤1. Secondary outcomes included adverse events (AEs), t
Like
Comment
Share
